Cochlear (ASX: COH) is a global biotechnology company that designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.Based in Sydney, Cochlear was formed in 1981 with finance from the Australian government to commercialise the implants pioneered by Dr Graeme Clark.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| foaf:homepage | |
| founding year |
|
| industry | |
| location | |
| net income ($) |
|
| number of employees |
|
| product | |
| type | |
| is successor of |